Better Healthcare Dividend Stock: Abbott Labs Or Abbvie?

Abbott Laboratories (ABT) spun off its major pharmaceutical business AbbVie (ABBV) in December 2012.

The rationale for the spin-off was that it would allow Abbott to focus on its balanced health care business, which is split among medical devices, consumer products, and international pharmaceuticals.

At the same time, Abbott management believed AbbVie, as a growth company, would earn a higher valuation multiple if it were trading on its own.

It’s clear that management was right. Since the

What feeling does this article give you?

#hashtags to follow:

Abbott Laboratories [+]    ABT [+]    AbbVie [+]    ABBV [+]    December 2012 [+]   

More #news: